Jorge Benozzi1, Lucio P Nahum, Julieta L Campanelli, Ruth E Rosenstein. 1. Laboratory of Retinal Neurochemistry and Experimental Ophthalmology, Department of Human Biochemistry, Faculty of Medicine, University of Buenos Aires-Paraguay 2155, 1121 Buenos Aires, Argentina.
Abstract
PURPOSE: To study the effect of acute or chronic intracameral injection of hyaluronic acid on intraocular pressure (IOP) in rats. METHODS: Acute or chronic injections of hyaluronic acid were performed unilaterally in the rat eye's anterior chamber, whereas the contralateral eye was injected with saline solution. IOP was assessed daily or weekly by a tonometer in conscious rats. IOP was also assessed in both experimental groups at several intervals during the light-dark cycle. RESULTS: A single injection of hyaluronic acid induced an increase of IOP that lasted for 8 days (P < 0.01), whereas its chronic administration during 9 weeks induced a significant and sustained increase in IOP, compared with the eye injected with vehicle (P < 0.01). This hyaluronic acid-induced hypertension was significantly decreased by the application of 1 drop of brimonidine (0.2%), latanoprost (0.005%), or timolol (0.5%). Significant daily variations of IOP were observed in both control and hyaluronic acid-injected eyes, peaking during the dark phase (P < 0.001, ANOVA). CONCLUSIONS: These results suggest that the intracameral administration of hyaluronic acid could be a model of ocular hypertension in rats.
PURPOSE: To study the effect of acute or chronic intracameral injection of hyaluronic acid on intraocular pressure (IOP) in rats. METHODS: Acute or chronic injections of hyaluronic acid were performed unilaterally in the rat eye's anterior chamber, whereas the contralateral eye was injected with saline solution. IOP was assessed daily or weekly by a tonometer in conscious rats. IOP was also assessed in both experimental groups at several intervals during the light-dark cycle. RESULTS: A single injection of hyaluronic acid induced an increase of IOP that lasted for 8 days (P < 0.01), whereas its chronic administration during 9 weeks induced a significant and sustained increase in IOP, compared with the eye injected with vehicle (P < 0.01). This hyaluronic acid-induced hypertension was significantly decreased by the application of 1 drop of brimonidine (0.2%), latanoprost (0.005%), or timolol (0.5%). Significant daily variations of IOP were observed in both control and hyaluronic acid-injected eyes, peaking during the dark phase (P < 0.001, ANOVA). CONCLUSIONS: These results suggest that the intracameral administration of hyaluronic acid could be a model of ocular hypertension in rats.
Authors: Rebecca M Sappington; Brian J Carlson; Samuel D Crish; David J Calkins Journal: Invest Ophthalmol Vis Sci Date: 2009-10-22 Impact factor: 4.799
Authors: Da Zhao; Christine T O Nguyen; Vickie H Y Wong; Jeremiah K H Lim; Zheng He; Andrew I Jobling; Erica L Fletcher; Holly R Chinnery; Algis J Vingrys; Bang V Bui Journal: Front Neurosci Date: 2017-02-10 Impact factor: 4.677
Authors: Jie Zhang; Liang Li; Haoliang Huang; Fang Fang; Hannah C Webber; Pei Zhuang; Liang Liu; Roopa Dalal; Peter H Tang; Vinit B Mahajan; Yang Sun; Shaohua Li; Mingchang Zhang; Jeffrey L Goldberg; Yang Hu Journal: Elife Date: 2019-05-15 Impact factor: 8.140
Authors: Carolina Nunes da Silva; Lays Fernanda Nunes Dourado; Maria Elena de Lima; Armando da Silva Cunha-Jr Journal: Transl Vis Sci Technol Date: 2020-07-22 Impact factor: 3.283